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The aim of this study was to better understand the role of the
endothelin-1 (ET-1) system in the process of controlling the
corpora lutea (CL) life span in rabbits. ET-1 (10 g iv) admin-
istration at d 9 and 12 of pseudopregnancy induced a func-
tional luteolysis within 24 h of injection, but it was ineffective
at both d 4 and 6. Pretreatments with Bosentan, a dual ETA/
ETB receptor antagonist, or cyclooxygenase (COX) inhibitor
blocked the luteolytic action of ET-1 but not that induced by
prostaglandin F2 (PGF2). In CL cultured in vitro, ET-1 in-
creased (P < 0.01) both PGF2 production and luteal nitric
oxide synthase activity but decreased (P< 0.01) progesterone
release. Addition of ETA receptor antagonist BQ123 or COX
inhibitor blocked the ET-1 luteolytic effects. Positive staining
for ET-1 receptors was localized in ovarian blood vessels,
granulosa cells of large follicles, and luteal cells. Immunoblot
analysis of ET-1 receptor protein revealed a strong band of
approximately 48kDa ind-9CL.Up tod6of pseudopregnancy,
ET-1 mRNA abundance in CL was poorly expressed but then
increased (P < 0.01) at d 9 and 13. ETA-receptor transcript
increased (P < 0.01) at d 6, remained at the same level up to d
13, and then declined to the lowest (P < 0.01) levels at d 22.
ETB-receptor mRNA increased (P< 0.01) throughout the late-
luteal stage from d 13 up to d 18. Our data suggest that the
luteolytic action of ET-1 may be a result of PGF2 synthesis
from both luteal and accessory cells, via the COX pathways.
(Endocrinology 146: 1293–1300, 2005)
IN PSEUDOPREGNANT RABBITS, LUTEOLYSIS nor-mally begins around d 14 and is completed a few days
later when blood progesterone declines to basal values (1). In
this species, as in many others, besides prostaglandin F2
(PGF2), several other factors are now recognized to regulate,
via paracrine and/or autocrine mechanisms, the life span of
corpora lutea (CL) from formation to regression (2–5).
An increasing amount of compelling evidence supports
the hypothesis that endothelin-1 (ET-1), a potent vasocon-
strictor synthesized by vascular endothelium, may promote
the cascade mechanism of luteolysis triggered by PGF2 (6,
7). ET-1 was found to inhibit progesterone release by gran-
ulosa and luteal cells of various species in a number of
systems (8–11). In addition, highly specific receptors for ET-1
(ET-1R) were identified on steroidogenic luteal cells, and
their abundance as well as ET-1 expression (12) increased
during luteal demise (7, 11, 13). Moreover, PGF2 injection
rapidly increased ET-1 release within the regressing CL, as
well as into the ovarian venous blood, in cattle (14). Con-
versely, ET-1 was found to enhance intraluteal PGF2 pro-
duction (15, 16), and this mechanism may have a critical role
in complete luteal regression (17).
ET-1 was found to stimulate endothelial nitric oxide (NO)
synthase (NOS) in different physiopathological conditions
(18, 19), and the NO/NOS system is known to be involved
in luteal regression induced by PGF2 (20) as well as by ET-1
(21). However, despite the emerging impact of this vasoac-
tive peptide on luteal function, the underlying ET-1-depen-
dentmechanisms that control the life span of CL, and that are
physiologically involved in the luteolytic process of the rab-
bit, are still unclear. Similarly, little is known about what
mechanisms protect the CL from luteolysis until d 6 of pseu-
dopregnancy, when CL shift from complete refractoriness to
partial and complete responsiveness to PGF2 treatment (22).
Thus, the main objectives of this study were to 1) localize,
within the ovary of rabbits, the cell type distribution of ET-
1R, 2) characterize the gene expression of both ET-1 and its
receptor subtypes, ETAR and ETBR, in CL at different luteal
stages throughout pseudopregnancy, and 3) verify the lu-
teolytic action of ET-1 in vitro as well as in vivo at different
days of pseudopregnancy. We further investigated, in the
same animal model, the interactions of the ET-1 system with
PGF2 and NOS, using cyclooxygenase (COX) enzyme in-
hibitors and different receptor antagonists for ET-1.
Materials and Methods
Reagents
Random hexamer primers, deoxyribonuclease I (amplification
grade), ribonuclease (RNase) H-reverse transcriptase (Superscript II),
Escherichia coli RNase H, and DNA ladders were obtained from Invitro-
gen (S. Giuliano Milanese, Milan, Italy) as well as reagent for isolation
andpurification of total RNA (TRIzol),TaqDNApolymerase (Platinum),
RNase-free tubes and RNase-free water, and deoxy-NTPs. Primers for
18S rRNA and corresponding competimers (QuantumRNA 18S internal
standards) were acquired from Ambion (Austin, TX). Primers for mR-
NAs of ET-1R, ETAR, and ETBR were supplied by Maxim Biothec Inc.
(San Francisco, CA). Tritiated hormones and [2,3-3H]l-arginine, having
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a specific activity of 30–40 Ci/mmol, were purchased from Amersham
Biosciences (Amersham Biosciences Ltd., Little Chalfont, UK), whereas
progesterone and PGF2 antisera and nonradioactive hormones came
from Sigma Chemical Co. (St. Louis, MO). The NOS detection assay kit
was purchased from Alexis Corp. (La¨ufelfingen, Switzerland). The pri-
mary monoclonal antibody anti-ET-1R, used for immunohistochemistry
and protein blotting, was supplied by BD Biosciences (Franklin Lakes,
NJ). The biotinylated secondary antibody, goat antimouse IgG used for
immunohistochemistry, was purchased from Vector Laboratories (Bur-
lingame, CA), whereas the horseradish peroxidase-conjugated chicken
antimouse IgG, employed for Western blot, came from Santa Cruz Bio-
technology (Santa Cruz, CA). The avidin-biotin complex (ABC, Vector
Elite Kit) and the chromogen 3,3-diaminobenzidine tetrachloride (DAB)
were from Vector Laboratories. The kit for the assay of protein was
purchased from Bio-Rad Laboratories (Hercules, CA). Nitrocellulose
membranes, Protran BA 85, for Western blot analysis were obtained
from Schleicher & Schuell (Dassel, Germany).
Incubationwellswere obtained by BectonDickinsonCo. (Clifton,NJ).
Medium199 andEarle’s balanced salt solutionwere fromGIBCO (Grand
Island, NY). HEPES and BSA were purchased from Sigma, whereas all
other pure grade chemicals and reagents were obtained locally.
ET-1 was purchased from Calbiochem (San Diego, CA), whereas
Bosentan (Ro 47-0203), a dual ETAR/ETBR antagonist, was kindly pro-
vided by Actelion Pharmaceuticals Ltd. (Allschwil, Switzerland). BQ123
and BQ788, specific receptor antagonists, respectively, for receptor type
A and type B of ET-1 as well as COX inhibitors, acetylsalicylic acid, and
indomethacin were all obtained from Sigma. The following hormonal
preparations were administered via im injection: GnRH analog (Recep-
tal, Hoechst-Roussel Vet, Milan, Italy), pregnant mare serum gonado-
tropin (Folligon, Intervet, Milan, Italy), and alfaprostol (Gabbrostim,
Centralvet, Milan, Italy), a PGF2 analog.
Animals, hormonal regimen, and tissue collection
Unmated New ZealandWhite rabbits, 5 months of age and weighing
3.5–3.8 kg, were caged individually in quarters of the University of
Perugia Central Animal Facility and maintained under controlled con-
ditions of light (14 h light, 10 h dark) and temperature (18C). The animals
were provided commercial rabbit chow and tap water for drinking ad
libitum. All rabbits were treated with 20 IU pregnant mare serum go-
nadotropin followed 3 d later by an im injection of 0.8 g GnRH to
induce pseudopregnancy. The day of GnRH injection is designated d 0.
This hormonal protocol was effective in inducing pseudopregnancy.
Rabbits were killed by cervical dislocation at the appropriate day of
pseudopregnancy. Reproductive tracts, promptly removed from each
animal, were washed throughout with saline. Within a fewminutes, the
CL were excised from ovaries and, after careful dissection of nonluteal
tissue by fine forceps under stereoscopic magnification, immediately
processed for in vitro studies and blotting analysis or, after rinsing with
RNase-free PBS, frozen at –80 C for later evaluation of gene expression.
The protocols involving the care and use of the animals for these
experimentswere approved by the Bioethic Committee of theUniversity
of Perugia.
Immunohistochemistry of ET-1R
For the immunohistochemical detection of ET-1R, three animals were
killed by cervical dislocation at d 9 of pseudopregnancy. The ovaries,
immediately removed after killing, were quickly frozen in liquid nitro-
gen and then stored at 80 C. Serial 7-m-thick frozen sections,
mounted on poly-l-lysine-coated glass slides, were placed into cold
acetone at a temperature ranging from 10 to 25 C for 10 min. All
subsequent steps were carried out in a moist chamber at room temper-
ature. The sections were first treated with a 0.5% solution of hydrogen
peroxide in methanol for 10 min to inactivate the endogenous pseu-
doperoxidase activity and then rinsed with PBS solution and incubated
for 30 min with normal goat serum to minimize the nonspecific binding
of reagent in subsequent steps. The primary antiserum, mouse anti-
ET-1R antibody (no. 611252) was diluted 1:50 in PBS and left on sections
overnight. The next day, sections were washed in PBS and incubated
with a biotinylated secondary antibody (1:200 in PBS) for 30 min. After
PBSwashes, sectionswere exposed to avidin-biotin-peroxidase complex
(1:2500 in PBS) for 30 min, followed by the chromogen DAB for 5 min,
to visualize the site of reaction. After washing in tap water, the ovary
sections were dehydrated and mounted in Canada balsam natural. Pos-
itive reactions were recognized as reddish-brown precipitates. Sections
in which the primary antibody was omitted or substituted by preim-
mune mouse -globulin were used for the negative control of nonspe-
cific staining.
Western blot analysis
For the Western blot analysis of ET-1R, CL were harvested from two
rabbits at d 9 of pseudopregnancy and processed as described previ-
ously (23). Briefly, total proteinswere extracted from a pool of 10 CL that
was homogenized in 1 ml ice-cold RIPA buffer (PBS containing 1%
Igepal CA-630, 0.5% sodium deoxycholate, 0.1% SDS) with added pro-
tease inhibitor cocktail EDTA-free (Roche, Mannheim, Germany) using
an Omni-Umixer (Analytical Control, Dasit, Cinisello Balsamo, Milan,
Italy). After incubation at 4 C for 20 min, the homogenates were cen-
trifuged at 25,000 g for 60 min at 4 C. The supernatants were collected
and their protein concentrations measured using the protein assay kit
with BSA as standard. After heating at 95 C for 5 min, equivalent
amounts of proteins (60 g) were separated using an electrophoresis
system (Mini-Protean; Bio-Rad) by discontinuous 10% SDS-PAGE with
4% staking gel for 40min at 200 V and 500mA, after which proteinswere
transferred onto a nitrocellulose membrane for 1 h at 100 V and 350 mA.
After transfer, membranes were blocked with PBS containing 0.5% ca-
sein. The membrane was incubated overnight at 4 C with anti ET-1R
primary antibody diluted at 1:1000. Subsequently, membranes were
probed with a chicken antimouse IgG-peroxidase antibody at 1:1000
dilution for 60 min at room temperature under gentle agitation. All
antibody incubationswere performed in PBS containing 0.5% casein and
washing in PBS with 0.05% Tween 20. Immunoreactive bands were
developed using DAB substrate kit for peroxidase at room temperature
for 5 min. Prestained protein molecular weight markers (Bio-Rad) were
used as molecular weight references. Blot images were acquired with an
HP scanner.
RNA extraction and RT
To study the gene expression for ET-1, ETAR, and ETBR, CL were
collected from five rabbits at d 4, 6, 9, 13, 15, 18, and 22 of pseudopreg-
nancy. For each rabbit, total RNA was extracted from a pool of six to 10
CL, which was homogenized by Omni-H in 1 ml of the solution
provided with Trizol using the procedure as described by the manu-
facturer. Concentration of total RNA (OD260), and purity (OD260/280,
OD260/230) was determined spectrophotometrically (BioPhotometer, Ep-
pendorf srl, Milan, Italy). The integrity of each sample was assessed by
electrophoresis of an aliquot of 3 g RNA in agarose formaldehyde gel
using ethidium bromide staining. Genomic DNA contamination was
prevented by treatment with deoxyribonuclease I according to instruc-
tions. Total RNA (5 g; 1 g/l) was reverse transcribed into cDNA in
a 20-l final reaction mixture of iSCRIPT cDNA synthesis kit (Bio-Rad).
GenomicDNAcontaminationwas checked by carrying samples through
the PCR procedure without reverse transcriptase. The RT products were
stored at –20 C.
Muliplex RT-PCR amplification
An aliquot (1.0l) of cDNAwas used as a template for the subsequent
semiquantitative PCR amplification reaction. PCR (25.0 l) was per-
formedwith 0.2lTaqDNApolymerase (5U/l), 1.0l dNTPs (10mm),
5.0 l 10 Taq buffer, 1.0l (10 m) of both forward and reverse primers
(Table 1) in two sets: the first for ET-1, ETAR, and housekeeping gene 18S
rRNA and the second for ETBR and 18S rRNA. The semiquantitative
PCR were carried out as reported previously (3). Preliminary experi-
ments were carried out to establish the optimal ratio between 18S prim-
ers and their competimers. Between 30 and 40 cycles, both target and 18S
products were in a linear exponential phase of amplification (data not
shown). Tominimize errors,within each experiment, the target genewas
coamplified with housekeeping 18S primers at the same PCR cycle.
Amplification was performed on a thermal cycler (GeneAmp, PCR Sys-
tem, PerkinElmer Biosystems, Foster City, CA). All PCR consisted of a
first denaturizing cycle at 94 C for 75 sec, followed by an amplification
profile of 35 reaction cycles with a first denaturizing cycle at 94 C for 15
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sec, followed by annealing at 60 C for 30 sec and extension at 72 C for
45 sec, and a final extension step at 72 C for 10 min. Within each
experiment and for each gene analyzed, the complete set of samples was
processed in parallel in a single PCR, using aliquots of the same PCR
master mix. Each set of determinations was performed in triplicate. The
18S rRNA is an ideal internal control for quantitative RNA analysis
because its expression remains invariant across tissues and treatments.
However, the relative high abundance of 18S rRNAmakes it difficult to
use in RT-PCR experiments because target mRNA species are by far less
abundant. However, by mixing appropriate amounts of 18S primers
with their competimers, primers modified only at their 3 ends to block
extension by DNA polymerase, the PCR amplification efficiency of 18S
cDNA can be reduced to a level roughly similar to that of the gene under
study.
Analysis of amplification products
The amplified PCR-generated products (20 l of 25-l total reaction
volume) were analyzed by electrophoresis on 2% agarose gel using
ethidium bromide staining. One product for each day of pseudopreg-
nancy was electrophoresed on a single gel together with a negative
control that contained no RNA and standard DNA ladder. The images
of gels were acquired by using a Kodak DC290 digital camera. The
background-corrected band intensities (absolute OD subtracted by the
background levels from corresponding lanes) for each PCR product
were quantified using Quantity One software (Bio-Rad). To evaluate the
temporal changes in relative levels of mRNAs, the band intensities for
the target genes of interest obtained from each aliquot of PCR products
were normalized against those of the housekeeping 18S mRNA coam-
plified product in the same aliquot. Values were expressed as arbitrary
units of relative abundance of the specific target genes.
In vivo induction of luteolysis
ET-1 was dissolved in saline at a concentration of 10 g/ml and
administered iv via a catheter inserted in the central ear vein. Bosentan
was injected in the vein at a dosage of 10 mg/kg. Appropriate dilutions
were prepared immediately before use, using sterile, double-distilled
water. The solution was gently warmed at 50 C for a few minutes to
completely dissolve the compound and then cooled at room temperature
before use. The dosage protocol chosen for Bosentan was based on
pharmacological data recently published (24). Indomethacin was in-
jected im 1 h before ET-1 or PGF2 administration.
Experiment 1. At different luteal stages, at d 4, 6, 9, and 12 of pseudo-
pregnancy, two groups of rabbits (n 5 per group per day) were treated
with saline or 10 g ET-1 dissolved in saline (1 ml), administered iv.
Experiment 2.Ond 9 of pseudopregnancy, rabbits (n 5 per group)were
randomly assigned to receive one of the following treatments: saline,
Bosentan (10mg/kg), indomethacin (10mg/kg), ET-1 (10 g), ET-1 plus
Bosentan, ET-1 plus indomethacin, PGF2 (100 g), PGF2 plus Bosen-
tan, and PGF2 plus indomethacin.
From each rabbit, blood samples were collected by venipuncture of
themarginal ear vein every 3 d during pseudopregnancy and just before
(basal) and 2, 4, 8, 24, and 48 h after treatment. The samples, collected
in EDTA-containing tubes, were immediately centrifuged at 3000 g for
15min, and the plasmawas stored frozen until assayed for progesterone
concentrations to assess the functional status of CL. Complete functional
luteolysis was defined as a decline of plasma progesterone concentra-
tions to values less than 1.0 ng/ml, which are normally observed in the
estrous rabbit (25).
In vitro incubations
For the in vitro study, d-9 CL were randomly distributed (one CL per
well) into incubation wells in 1 ml of culture medium 199 with Earle’s
balanced salt solution containing 2.2mg/ml sodium bicarbonate, 2.3 mg
HEPES, and 3% BSA, referred to here as M199. Before treatment, the CL
were quartered inside each well using fine forceps. Each incubation set
ofwellswas divided into 13 experimental groups of fivewells as follows:
1) medium alone as control, 2) ET-1 (100 m), 3) ET-1 plus ETAR an-
tagonist BQ123 (100 nm), 4) ET-1 plus ETBR antagonist BQ788 (100 nm),
5) ET-1 plus both ETAR and ETBR antagonists, 6) ETAR antagonist, 7)
ETBR antagonist, 8) both ETAR and ETBR antagonists, 9) ET-1 plus COX
inhibitor acetylsalicylic acid (2 m), 10) COX inhibitor, 11) PGF2 (3 m),
12) PGF2 plus ETAR antagonist, and 13) PGF2 plus COX inhibitor. The
culture plates were incubated at 37 C in air with 5% CO2 as reported
elsewhere (26). The media of each well were collected after 4 h of
incubation and stored immediately at 20 C for later determination of
progesterone and PGF2. Each CLwas weighed and stored immediately
at 20 C for later determination of NOS activity. Preliminary evidence
led to our choosing the incubation conditions and theminimumeffective
dose for ET-1 used in the present in vitro study (data not shown).
Progesterone and PGF2 assays
Progesterone and PGF2 concentrations were determined by RIA,
using specific antibodies according to the procedure reported elsewhere
(27). Progesterone and PGF2 were extracted from corresponding sam-
ples with ethyl ether. For extraction, 0.1 ml plasma and 0.2 ml culture
medium were used, and each sample was assayed in duplicate. The
assay sensitivity was 0.08 ng/ml for progesterone and 19 pg/ml for
PGF2. Intra- and interassay coefficients of variationswere 5.3 and 10.2%
for progesterone and 8 and 12% for PGF2.
NOS activity determination
NOS activity was determined in the same CL used for in vitro incu-
bations by monitoring the conversion of [3H]l-arginine into [3H]l-
citrulline using a commercial NOS assay kit according to the procedure
previously described (27). Briefly, the CL of each well was homogenized
in 1 ml of cold fresh homogenizing buffer (50 mm Tris, 1 mm EDTA, and
1 mm EGTA, pH 7.4) and centrifuged at 20,000  g for 60 min at 4 C.
Twenty-five microliters of supernatant and 100 l of incubation buffer
(1.5 mm NADPH, 1 mm CaCl2) containing 150,000 dpm [
3H]l-arginine
were added to the incubation tube. After 30 min of incubation at room
temperature, the enzymatic reaction was stopped by the addition of 2
ml blocking buffer (20 mm HEPES, 2 mm EDTA, pH 5.5). The mixture
was applied to a preequilibrated column (20 mm sodium acetate, 2 mm
EDTA, 0.2 mm EGTA, pH 5.5; 1 cm diameter) containing 1 ml Dowex
AG50W-X8 (Sigma), and the material was eluted with 2 ml water. [3H]l-
Citrulline was quantified in a liquid scintillation system (LS 1801; Beck-
man Instruments, Fullerton, CA). Additional determinations were per-
formed in the presence of excess of NOS inhibitor (N--nitro-l-arginine
methyl ester; Sigma) to verify the specificity of the assay for production
of [3H]l-citrulline by NOS (data not shown). Protein concentration was
determined by Bio-Rad protein assay kit.
Statistical analysis
The ratios of each PCR product for target genes (ET-1, ETAR, and
ETBR) normalized against 18S coamplified product were analyzed by
two-way ANOVA (day of pseudopregnancy and gel as the two sources
of variability) and Newman-Keuls multicomparison posttest. Proges-
terone, PGF2, and NOS data were evaluated by ANOVA for repeated
measures using the general linear model procedure of the Statistical
Analysis System Institute (28). Means obtained were compared using a
Student’s t test (option PDIFF).
TABLE 1. Primers for ET-1, ETAR, ETBR, and 18S used as
internal standard
Gene Length (bp) Primers (5–3)
ET-1 193
Sense caa gcg gtg ctc ctg ctc ct
Antisense gct cgt gca ctg gca cct gtt
ETAR 263
Sense gcg tcg gga agt ggc aaa ga
Antisense agc agc agc aga ggc acg ac
ETBR 116
Sense cct cct ccg tgt cag aga cc
Antisense att cgc agc agt gta gag ttc c
18S 489
Sense tcaagaacgaaagtcggaggtt
Antisense ggacatctaagggcatca
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Results
ET-1R immunolocalization in rabbit ovary and Western
blot analysis
Using amonoclonal antibody, evident positive staining for
ET-1R was localized in both endothelial and smooth muscle
cells of large ovarian blood vessels (Fig. 1A). Clear positive
staining was also identified in granulosa cells of large folli-
cles, in smoothmuscle cells of the external theca, and in some
steroidogenic cells of the interstitial gland (Fig. 1B). Only
weak positive reaction was localized in luteal cells and in
smooth muscle cells of the luteal wall (Fig. 1C). Staining was
completely abolished when the primary antibody was sub-
stituted with nonimmune serum (Fig. 1D).
Western blot analysis of ET-1R protein revealed a strong
band of approximately 48 kDa from whole protein extracts
of all the rabbit CL examined, whereas no band was visible
when incubation with the primary antibody was omitted
(data not shown).
Gene expression for luteal ET-1, ETAR, and ETBR mRNAs
The expression of 18S rRNA in rabbit CL remained fairly
constant, independently of the luteal phases. The corre-
sponding base pair amplification products obtained using
primers designed for each gene matched the expected size
(Figs. 2 and 3, bottoms).
Up to d 6 of pseudopregnancy, ET-1 mRNA abundance
was poorly expressed but then increased (P 0.01) at d 9 and
13 (Fig. 2, upper left). Thereafter, ET-1 transcript dropped
again to the low levels of the early luteal stage with an
increase (P  0.05) at d 22.
Over the study period, ETAR transcript in CL increased
(P 0.01) from d 4 to d 6 of pseudopregnancy, remaining at
the same level up to d 13, and then gradually declined to
reach the lowest (P  0.01) levels at d 22 (Fig. 2, upper right).
ETBR mRNA relative abundance did not show any clear
pattern in its steady-state up to d 9 of pseudopregnancy
when it increased (P  0.01) throughout late-luteal stage up
to day 18 (Fig. 3, upper).
In vivo response to ET-1 treatment
In control rabbits, blood progesterone did not decline dur-
ing the following 48 h after saline injection, ranging between
6 and 14 ng/ml according to the day of pseudopregnancy
(Fig. 4). ET-1 was totally ineffective when administered at d
4 or 6 of pseudopregnancy as evidenced by progesterone
profiles closely overlapping those of corresponding controls
(Fig. 4, upper left and right, respectively). Conversely, at both
d 9 and 12, ET-1 induced a functional luteolysis within 24 h
after injectionwhen plasma progesterone declined (P 0.01)
to values less than 1 ng/ml (Fig. 4, lower left and right,
respectively).
At d 9 of pseudopregnancy, the time course of the fall in
peripheral plasma progesterone evoked by ET-1 (Fig. 5A)
closely paralleled that found in PGF2-treated rabbits (Fig.
5B). Pretreatment with Bosentan, an antagonist for both
FIG. 1. Cellular localization of ET-1R in the ovary of rabbits obtained
at d 9 of pseudopregnancy. A, Strong positive staining in endothelial
cells (ec) and in smooth muscle cells (smc) of large ovarian vessels
(magnification,1000); B, a clear positive reaction in granulosa cells
(gc) of a large follicle, in smooth muscle cells of the external theca
(tmc), and in some steroidogenic cells (sc) of the interstitial gland
(500); C, a weak expression of ET-1R in the foamy cytoplasm of
luteal cells (lc) and in smooth muscle cells of the luteal wall (wmc)
(1000); D, a control section in the absence of primary antibody with
no reaction in granulosa cells of a large follicle, theca (th), and ste-
roidogenic cells of the interstitial gland (500).
FIG. 2. Gene expression patterns of ET-1 and ETAR mRNAs in CL of
rabbits freshly collected at d 4, 6, 9, 13, 15, 18, and 22 of pseudo-
pregnancy. Bottom, Representative photograph of a typical 2% aga-
rose, ethidium bromide-stained gel, showing the presence of the ex-
pected base pair products yielded after RT-PCR using primers for
target ET-1, ETAR, and 18S. Lane LD is the kilobase DNA marker,
lane PCR– represents a negative control of non-reverse-transcribed
RNA submitted to PCR amplification, whereas the other lanes iden-
tify the corresponding days of pseudopregnancy.Top, Summary of the
data (means  SEM) derived from densitometric analyses of the ET-1
(left) andETAR (right) inCL reported in arbitrary units relative to 18S
expression. The values combine the results from five different rabbits
for each luteal age.Different letters above bars indicate a significantly
different value (a and b, P  0.01; c, P  0.05).
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ETAR and ETBR, completely abolished the luteolytic action of
ET-1 at d 9 of pseudopregnancy (Fig. 5A), but did not prevent
that evoked by PGF2 (Fig. 5B). The ET-1-induced functional
luteolysis at d 9 of pseudopregnancywas also inhibitedwhen
rabbits were pretreated with the COX inhibitor indometha-
cin (Fig. 5A). In contrast, indomethacin pretreatment did not
influence the luteolytic action of PGF2 (Fig. 5B).
Treatment with both Bosentan or indomethacin alone did
not modify the luteal activity and the life span of CL during
the following 48 h (data not shown).
In vitro cultured CL
ET-1 decreased (P  0.01) progesterone release in CL cul-
tured in vitro (Fig. 6A) but increased (P  0.01) PGF2 se-
cretion and NOS activity (Fig. 6, B and C, respectively).
Coincubation of ET-1 with the ETAR antagonist alone (Fig. 6)
or with both ETAR and ETBR antagonists (data not shown)
completely abolished the ET-1-dependent effects on both
hormones and NOS activity. Conversely, ETBR antagonist
did not affect the ET-1 actions (Fig. 6). COX inhibitor blocked
the luteolytic action of ET-1 on progesterone release, reduced
(P  0.01) PGF2 secretion, and markedly down-regulated
(P  0.01) the NOS activity (Fig. 6). Treatment with PGF2
alone or with ETAR antagonist mimicked the same effects
induced by ET-1 on both progesterone production and NOS
luteal activity (Fig. 6). These PGF2-dependent effects were
not influenced by addition of COX inhibitor (Fig. 6, A andC).
COX inhibitor decreased (P  0.01) PGF2 release and NOS
activity in CL cultured in vitro (data not shown). ETAR and
ETBR antagonists alone or together did not affect hormonal
and enzymatic responses (data not shown).
Discussion
The present study demonstrates the cell localization of
ET-1Rwithin rabbit ovary, its protein expression inwholeCL
extracts, and the dynamic regulation of ET-1, ETAR, and
ETBR genes in the whole course of pseudopregnancy. More-
over, by studying the luteolytic action of ET-1, our in vivo
FIG. 4. Plasma progesterone levels after injection (arrow) of saline
(dotted line) or 10 g endothelin-1 (solid line) at d 4, 6, 9, and 12 of
pseudopregnancy. Values are mean SEM for five animals per group.
*, Significantly different from control at P  0.01.
FIG. 5. A, Plasma progesterone levels just before and after injection
of saline (control), ET-1 (10 g), ET-1 plus Bosentan (10 mg/kg), a
nonselective ETAR/ETBR antagonist, or ET-1 plus indomethacin (10
mg/kg) given at d 9 of pseudopregnancy; B, progesterone concentra-
tions after administration of PGF2 (100g of alfaprostol), PGF2plus
Bosentan, or PGF2 plus indomethacin. Values are mean  SEM
for five animals per group. *, Significantly different from control at
P  0.01.
FIG. 3. Gene expression patterns of ETBR mRNAs in CL of rabbits
collected at d 4, 6, 9, 13, 15, 18, and 22 of pseudopregnancy. Bottom,
Representative photograph of a typical 2% agarose, ethidium bro-
mide-stained gel, showing the presence of the expected base pair
products yielded after RT-PCR using primers for target ETBR and
18S. Lane LD is the kilobase DNA marker, lane PCR–represents a
negative control of non-reverse-transcribed RNA submitted to PCR
amplification, whereas the other lanes identify the corresponding
days of pseudopregnancy. Top, Summary of the data (means  SEM)
derived from densitometric analyses of the ETBR in CL reported in
arbitrary units relative to 18S expression. The values combine the
results from five different rabbits for each luteal age. Different letters
above bars indicate a significantly different value (P  0.01).
Boiti et al. • ET-1-Induced Luteolysis in Rabbits Endocrinology, March 2005, 146(3):1293–1300 1297
results showed that early-luteal-stage CL, at d 4 and 6 of
pseudopregnancy, are completely refractory to this vasoac-
tive peptide.
The ET-1 binding in the ovary has been characterized in
several species but, to date, not in rabbits. In the present
study, using an immunohistochemical technique, strongpos-
itive staining was found in the large ovarian blood vessels as
well as in the granulosa cells of large follicles and in some
steroidogenic cells of the interstitial gland. Conversely, luteal
cells showed a weak reaction. By means of autoradiography,
ETAR-binding siteswere detected on blood vessels of porcine
CL and in the granulosa cell layer of the maturing Graafian
follicles (29). Additional work, using RT-PCR on isolated
bovine luteal cells, recognized ETAR expression not only on
endothelial cells but also on steroidogenic luteal ones, both
large and small, although at a lower level (11). Both ETAR and
ETBRmessengerswere found in luteinized human (8) and rat
granulosa cells (30). Western blotting of the whole protein
fraction derived from luteal extracts yielded a strong band at
48 kDa when probed with a monoclonal antibody generated
by rat ET-1R; this was in good agreement with results ob-
tained in rat lungs (31).
Our results indicate that genes for ET-1 and for both its
receptor subtypes, ETA and ETB, are expressed, although at
different levels, in CL of rabbits throughout the course of
their life span, from early- to late-luteal stages across CL
demise up to d 22 of pseudopregnancy. This observation is
not surprising given that, within the rabbit CL, the endo-
thelial compartment contains approximately 30–40% whole
cells (32).
Gene expression of ET-1 increased with aging of CL from
early- tomid-luteal stages, at d 9 and 13when a rise occurred.
Thereafter, relative ET-1 mRNA abundance dropped, in co-
incidence with the fall of plasma progesterone concentra-
tions toward basal values, and rose again after luteal regres-
sion. In the rat luteal tissue, the highest ET-1 protein levels
were found in themid-luteal phase of pseudopregnancy (33),
which is in good agreement with our ET-1 mRNA results.
Conversely, in bovine CL, the ET-1 mRNA declined during
both mid- and late-luteal phases of the estrous cycle (34).
ETAR transcript was relatively highly expressed in the
mid-luteal phase but then gradually declined in the follow-
ing days during the transition from late-luteal stage to func-
tional regression. Surprisingly, however, ETARmRNA levels
were relatively up-regulated also at d 6 of pseudopregnancy,
when exogenous administration of ET-1 was ineffective in
provoking luteolysis. Thus, there is no clear relationship
between the luteal expression of ET-1 type A receptor and its
responsiveness to ET-1 in vivo. Contrary to what was found
in cows (11, 34), in our study there was a direct relationship
between ETAR gene expression and peripheral blood pro-
gesterone concentrations, which are a good marker of luteal
function. The transiently high ETAR mRNA levels between
d 6 and 13 of pseudopregnancy suggests, although indirectly,
that the corresponding receptors for ET-1 may be locally
regulated within the CL. It remains to be established, how-
ever, what factor is actually involved, whether progesterone,
ET-1 itself, or other substances.
In the present study, the ETBR mRNA increased during
late-luteal phase and during luteal regression, which is in
good agreement with previous observations in bovine CL
(34). Although the role of ETBR inCL is notwell documented,
our data suggest that the ETBR subtype may take part in the
whole luteolytic cascade related to structural demise rather
than to progesterone decline (13).
In the rabbit, the luteolytic action of ET-1 in vivowas clearly
dependent on CL age. The 4- and 6-d-old CL remained un-
affected by the same luteolytic dose of ET-1 as that which
caused a striking reduction of luteal function at d 9 and 12.
The reasons for this time-dependent responsiveness are still
unclear, given that both ET-1R subtypes are already ex-
pressed, at the gene level, from d 4 of pseudopregnancy at
approximately the same relative abundance as that found in
older CL. By profiling progesterone in blood, ET-1-induced
luteolysis, when effective at d 9 and 12, progressed similarly
to that triggered by PGF2 (22). Furthermore, ET-1-induced
luteolytic action in vivo was prevented by antagonizing re-
ceptors for ET-1 with Bosentan, an inhibitor of endothelin
receptor types A and B, or by blocking COX activity with
indomethacin.
In vitro, whereas ET-1 inhibited basal progesterone secre-
tion from CL, it stimulated PGF2 release, similarly to that
found in bovine luteal cells (15) and luteinized human gran-
ulosa cells (8). All these ET-1-dependent actions were abol-
ished by the ETAR highly selective antagonist BQ123 and not
by the ETBR antagonist, which is in good agreement with
other studies (8, 9). The luteolytic action of ET-1 was also
FIG. 6. In vitro effects of medium alone, ET-1, ET-1 plus ETAR antagonist (ETARa), ET-1 plus ETBR antagonist (ETBRa), ET-1 plus COX
inhibitor (COXi), PGF2, PGF2 plus ETARa, and PGF2 plus COXi on both progesterone (A) and PGF2 (B) releases and total NOS activity
(C) by rabbit CL obtained at d 9 of pseudopregnancy. Results are the means  SD of five replicates. Different letters above the bars indicate
significantly different values (P  0.01).
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counteracted by treatment with COX inhibitor, consistently
with our in vivo findings.
Collectively, the in vivo and in vitro findings presented here
strongly support the hypothesis that ET-1 may be part of an
amplifying cascade system that induces and sustains CL
regression in rabbits, its antisteroidogenic action being acti-
vated via an ETAR-mediated mechanism involving PGF2
synthesis. In fact, the luteolytic action of ET-1 was prevented
in vivo and in vitro, not only by administration of ET-1R
antagonist, as expected, but also by treatments with COX
inhibitors. Thus, coherent evidence suggests that the inhib-
itory action of ET-1 on progesterone release by CL may be a
result of an enhancement of PGF2 synthesis both from luteal
and accessory cells, via the COX pathways.
Taken together, these results suggest a physiological role
for the ET-1 system within this transient organ. In fact, there
is increasing evidence that ET-1 can modulate the angiogen-
esis process both directly and indirectly through the vascular
endothelial growth factor (35). The ET-1 system may play a
role in the early developing CL by driving luteal cell growth
in a paracrine fashion through transcriptional mechanisms
(36); in fact, evidence for a cross-talk between endothelial and
steroidogenic cells in the control of luteal functions has been
found in ruminants (5, 37, 38). ET-1 may also act as a local
mediator or promoter of CL regression by governing intra-
luteal PGF2 production (7, 16), a mechanism that has been
recognized to have a critical role for complete luteal demise
(17). Thus, ET-1 may be responsible for the increased sensi-
tivity of rabbit CL to luteolytic factors that occur at the proper
timing for the spontaneous luteolysis to progress (39).
However, whereas ET-1-induced functional luteolysis ap-
pears to be linked to the prostanoid pathway, PGF2, appar-
ently, does not require ET-1 to elicit its luteolytic action,
because pretreatment with the ET-1R antagonists did not
prevent functional luteal demise from occurring both in vivo
and in vitro. These results differ from those previously found
in ewes and cows,which provided evidence for claiming that
PGF2-induced luteolysis ismediated by ET-1 (9, 10). In these
species, in fact, pretreatment with ETAR antagonists greatly
mitigated the luteolytic effects of PGF2. In ruminants, a
strong positive feedback system between luteal ET-1 and
PGF2 has been described in which ET-1 increases PGF2
synthesis and release, whereas PGF2 up-regulates luteal
gene and protein expression of ET-1 concomitantly with the
decline of progesterone production by the CL (7, 10). Al-
though the reciprocal interactions between PGF2 and ET-1
in rabbits remain to be disclosed, the results of the present
work suggest, although indirectly, that othermediators, such
as angiotensin II (40) and leptin (41), may be involved in the
regulation of CL regression. Of note, in our experimental
model, both in vivo and in vitro pretreatments with COX
inhibitors did not modify the time course of the luteolytic
process primed by the exogenous administration of PGF2.
These findings, however, are not in conflict with the current
view that an autoamplification pathway, involving PGF2-
induced production of PGF2 by the CL, may be responsible
for complete luteolysis (5), because in our animal model we
employed a high luteolytic dose of PGF2.
The present results show that ET-1 enhanced the enzy-
matic activity of NOS, via ETAR activation mediated by
PGF2, given that both BQ123 and COX inhibitor abolished
its functional up-regulation. Nitric oxide is deeply involved
in the regulation of rabbit CL function, because PGE2 and
PGF2 luteotrophic and luteolytic effects are mediated by
NOS down- and up-regulation, respectively (27).
Even if the luteolytic outcome of the in vitro and in vivo
experiments here described was the same, the mechanism
activated by ET-1 treatment leading to a progesterone fall
may not necessarily be identical. The luteolytic effect of ET-1
in vivo, for example, can be ascribed to its potent vasocon-
strictor action, which may cause a critical reduction in ovar-
ian blood flow and oxygen supply to CL. Therefore, it would
be of interest to study the dynamic of blood flow in the
ovaries of rabbits treated with ET-1. In fact, the vasocon-
strictor action of ET-1 could be blunted or even reversed by
the local release of vasodilatory factors, including NO and
prostacyclin, induced by ET-1 itself after binding to its re-
ceptors localized in both endothelial and vascular smooth
muscle cells (42). Interestingly, years ago, PGF2, despite its
vasoconstrictor property, was found to cause a vasodilation
of the ovarian stroma in rabbits (43, 44). More recently, sim-
ilar results were also found in CL of mid-cycle cows given
that PGF2 in vivo induced an acute blood flow increase
followed by a decrease (45).
In conclusion, the presence of putative receptors for ET-1
in the vascular components and luteal cells suggests that the
ET-1 system is involved in the regulation of ovarian blood
flow and in steroidogenesis as well. The luteolytic effect of
ET-1 in the rabbit is mediated by a complex interaction with
PGF2 and the NO/NOS system, whose up- and down-
stream pathways after ET-1 binding have not yet been elu-
cidated. At present, taken together, our results suggest that
the luteolytic action of ET-1 can be ascribed either to vascular
mechanisms, because of its potent vasoconstrictor action that
causes a critical reduction in blood flow to ovary and CL,
and/or to activation of the PGF2 cascade mechanism me-
diated by NOS. It remains to be established what factors
actually protect CL against undergoing luteolysis prema-
turely, as well as the intracellular signaling cascade used by
ET-1 in rabbit CL.
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